Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Therapy01:28

Drug Therapy

219
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
219
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

417
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
417
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

412
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
412
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

750
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
750
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

437
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
437
Operant Conditioning Intervention01:24

Operant Conditioning Intervention

407
Operant conditioning serves as a foundational principle in therapeutic interventions aimed at modifying maladaptive behaviors. Central to this approach is the notion that behaviors, both adaptive and maladaptive, are learned through reinforcement. By analyzing the environmental factors that reinforce problematic behaviors, clinicians can design interventions to weaken these reinforcements and replace maladaptive behaviors with healthier alternatives.
In operant conditioning, behaviors that are...
407

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect of Medicaid reimbursement for psychiatrists on the health care burden of serious mental illness.

The American journal of managed care·2026
Same author

Outcomes of patients with COPD before and after initiation of treatment with budesonide/glycopyrrolate/formoterol fumarate: Results from the US ARCTOS study.

Respiratory medicine·2026
Same author

Healthcare Resource Utilization and Costs After Disease Progression With First-Line Systemic Therapy in Patients With Advanced Endometrial Cancer in the United States.

Value in health regional issues·2026
Same author

Benralizumab Reduces Asthma Exacerbations and Costs Among Medicare Beneficiaries with Severe Asthma: The ZEPHYR-5 Study.

Journal of asthma and allergy·2026
Same author

Prevalence and Healthcare Costs of Metabolic Disorders Among Individuals with Schizophrenia Following Initiation of Oral Antipsychotic Therapy.

PharmacoEconomics - open·2026
Same author

Effectiveness of Benralizumab in Reducing Asthma and COPD Exacerbations in Patients with Severe Asthma and Concomitant COPD: Real-World Evidence from the ZEPHYR-5 Study.

International journal of chronic obstructive pulmonary disease·2026

Related Experiment Video

Updated: Jan 1, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

18.9K

A claims-based algorithm to reduce relapse and cost in schizophrenia.

Heidi C Waters1, Charles Ruetsch, Joseph Tkacz

  • 1Otsuka Pharmaceutical Development & Commercialization, Inc, 508 Carnegie Center Dr, Princeton, NJ 08540.

The American Journal of Managed Care
|December 21, 2019
PubMed
Summary

This study refined an algorithm to identify high-risk schizophrenia patients for case management. The intervention showed a decrease in hospitalizations and emergency department visits, suggesting its effectiveness in reducing healthcare utilization.

More Related Videos

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.5K
A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder
07:51

A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder

Published on: June 18, 2018

11.0K

Related Experiment Videos

Last Updated: Jan 1, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

18.9K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.5K
A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder
07:51

A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder

Published on: June 18, 2018

11.0K

Area of Science:

  • Health Services Research
  • Psychiatric Epidemiology
  • Health Informatics

Background:

  • Schizophrenia relapse poses significant healthcare burdens.
  • Accurate identification of high-risk patients is crucial for effective intervention.
  • Managed care organizations seek algorithms to predict and mitigate patient relapse.

Purpose of the Study:

  • To refine a predictive algorithm for identifying schizophrenia patients at high risk of relapse.
  • To evaluate the effectiveness of a case management (CM) program utilizing this algorithm within a Medicaid population.

Main Methods:

  • A predictive algorithm was developed using Medicaid claims data (medical and pharmacy) from August 2009 to July 2014 for 12,353 schizophrenia patients.
  • The algorithm's performance was assessed using metrics like positive predictive power, negative predictive power, sensitivity, and specificity.
  • A case management program targeted the highest-risk patients identified by the algorithm, comparing outcomes (hospitalizations, ED visits) against a control group.

Main Results:

  • The refined algorithm demonstrated strong predictive capabilities: 64.0% positive predictive power, 94.7% negative predictive power, 40.2% sensitivity, and 97.9% specificity.
  • Following case management intervention, the CM group saw a decrease in inpatient admissions (23.3% to 13.3%) and a ~15% reduction in monthly ED visits.
  • Conversely, the control group experienced an increase in these adverse events.

Conclusions:

  • The developed algorithm shows promise as an effective case-finding tool for managed care plans.
  • The findings suggest the algorithm can aid in mitigating hospitalizations among high-risk schizophrenia patients.
  • Further research may be warranted to confirm statistical significance and optimize intervention strategies.